Lazard Asset Management
WVE icon

Lazard Asset Management’s Wave Life Sciences WVE Stock Holding History

Lazard Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-217
Closed -$2K – 2606
2024
Q4 		$2K Hold
217
– – ﹤0.01% 2196
2024
Q3 		$1K Sell
217
-230
-51% -$1.38K ﹤0.01% 2226
2024
Q2 		$2K Sell
447
-5,010
-92% -$28.6K ﹤0.01% 2118
2024
Q1 		$33K Sell
5,457
-1,214
-18% -$6.08K ﹤0.01% 1797
2023
Q4 		$33K Buy
6,671
+298
+5% +$1.59K ﹤0.01% 2000
2023
Q3 		$36K Buy
6,373
+333
+6% +$1.52K ﹤0.01% 1951
2023
Q2 		$21K Buy
6,040
+174
+3% +$703 ﹤0.01% 2092
2023
Q1 		$24K Buy
5,866
+4,238
+260% +$19.4K ﹤0.01% 2022
2022
Q4 		$11K Buy
+1,628
New +$7.5K ﹤0.01% 2195

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Lazard Asset Management's WVE Position: Q1 2025 in Review

Lazard Asset Management sold out of Wave Life Sciences (WVE) in Q1 2025, closing a stake of 217 shares — an estimated $2K sold.

Lazard Asset Management first reported a position in WVE in Q4 2022 and held it in 9 quarters. The position peaked at $36K in Q3 2023. 196 funds tracked by Wall St. Rank hold WVE as of Q1 2025.

  • Lazard Asset Management reported no remaining Wave Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 217 Wave Life Sciences shares in Q1 2025, an estimated $2K.
  • Lazard Asset Management first reported a position in Wave Life Sciences in Q4 2022 and held it in 9 quarters.
  • Lazard Asset Management's Wave Life Sciences position peaked at $36K in Q3 2023.
  • 196 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.